Warby Parker Inc.
NYSE:WRBYMedical - Instruments & Supplies
+$0.92 today
- Market cap
- $3.07B
- Beta
- 1.97
- P/E (TTM)
- 2305.1
- EPS (TTM)
- $0.01
Volume 5.90M
Average 2.81M
WRBY Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Warby Parker Inc.NYSE: WRBY
Other Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other current liabilities falls 94.6% from a year ago
Other current liabilities stood at $2.8M at the end of Q2 FY2026, down 94.6% from a year earlier and down 4.7% from the prior quarter. Over 3 fiscal years it compounded at +15.6% a year.
Context
- Other current liabilities amounted to 0.4% of total assets at the end of Q2 FY2026, down 7.0 pp from a year earlier.
- Other current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -94.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 3.66M USD
- Year-over-year change
- +38.9%
- 4-year CAGR
- -48.8%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.66M | +38.9% |
| FY2024 | 2024-12-31 | 2.63M | +9.2% |
| FY2023 | 2023-12-31 | 2.41M | +1.7% |
| FY2022 | 2022-12-31 | 2.37M | -95.6% |
| FY2021 | 2021-12-31 | 53.29M | — |
Other Current Liabilities vs competitors
How WRBY compares with its peers on the latest reported figures
- WRBY's Jun 2026 other current liabilities of $2.8M is the 7th highest of the 10 companies compared; the peer median is $67.47M.
- Its year-over-year change of -94.6% is the 7th highest of 8, against a peer median of -6.4%.
- Other current liabilities amounts to 0.4% of total assets for WRBY, versus a peer median of 1.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.2B | -12.0% | +28.7% | 4.8% | |
| Mar 2026 | $173.7M | +103.2% | +1.7% | 3.1% | |
| Jun 2026 | $163.8M | +69.8% | +12.5% | 6.9% | |
| Jul 2026 | $97.08M | +11.6% | +8.5% | 2.8% | |
| Jun 2026 | $67.47M | -6.4% | +46.2% | 1.7% | |
| Jun 2026 | $12.18M | -31.2% | -9.9% | 0.9% | |
| Jun 2026 | $2.8M | -94.6% | +15.6% | 0.4% | |
| Mar 2026 | $475K | — | -17.5% | 0.1% | |
CONConcentra Group Holdings Parent, Inc. | Sep 2026 | $0 | -100.0% | -12.6% | 0.0% |
| Mar 2026 | $0 | — | +30.9% | 0.0% | |
| Peer median (excluding WRBY) | $67.47M | -6.4% | +8.5% | 1.7% | |
Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 256.42M | 208.59M | 216.89M | 254.16M | 286.36M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 992K | 1.44M | 1.78M | 1.95M | 3.29M |
| Inventory | 57.1M | 68.85M | 62.23M | 52.35M | 44.51M |
| Other Current Assets | 0 | 15.7M | 17.71M | 17.59M | 18.28M |
| Total Current Assets | 327.98M | 294.57M | 298.62M | 326.05M | 352.44M |
| Property, Plant & Equipment (Net) | 112.2M | 265.64M | 274.64M | 341.75M | 358.25M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 8.6M | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 2M | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | (8.13M) | 8.5M | 7.06M | 6.7M | 10.23M |
| Total Non-current Assets | 112.67M | 274.14M | 281.69M | 350.44M | 368.48M |
| Total Assets | 440.65M | 568.71M | 580.31M | 676.49M | 720.92M |
| Account Payables | 30.89M | 20.79M | 22.46M | 23.52M | 31.98M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 22.07M | 25.63M | 31.62M | 32.36M | 33.87M |
| Other Current Liabilities | 53.29M | 2.37M | 2.41M | 2.63M | 3.66M |
| Total Current Liabilities | 118.1M | 129.56M | 127.09M | 130.35M | 150.13M |
| Long-term Debt | 0 | 0 | 0 | 0 | 201.75M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 36.54M | 1.67M | 1.26M | 943K | 1.31M |
| Total Non-current Liabilities | 36.54M | 152.5M | 151.44M | 206.06M | 203.06M |
| Total Liabilities | 154.65M | 282.06M | 278.53M | 336.42M | 353.19M |
| Common Stock | 11K | 12K | 12K | 12K | 12K |
| Retained Earnings | (493.24M) | (603.63M) | (666.83M) | (687.22M) | (685.58M) |
| Accumulated OCI | 16K | (647K) | (1.53M) | (1.94M) | (1.48M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 286M | 286.65M | 301.79M | 340.07M | 367.73M |
| Total Debt | 0 | 173.38M | 174.46M | 225.36M | 233.15M |
| Net Debt | (256.42M) | (35.21M) | (42.44M) | (28.81M) | (53.21M) |
Warby Parker Inc.
NYSE:WRBY
Intrinsic Alpha fair value
Locked
Current Price
$28.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.